Michelle Van Handel

1.7k total citations · 1 hit paper
30 papers, 1.3k citations indexed

About

Michelle Van Handel is a scholar working on Epidemiology, Infectious Diseases and General Health Professions. According to data from OpenAlex, Michelle Van Handel has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 17 papers in Infectious Diseases and 7 papers in General Health Professions. Recurrent topics in Michelle Van Handel's work include HIV, Drug Use, Sexual Risk (21 papers), HIV/AIDS Research and Interventions (17 papers) and Sex work and related issues (6 papers). Michelle Van Handel is often cited by papers focused on HIV, Drug Use, Sexual Risk (21 papers), HIV/AIDS Research and Interventions (17 papers) and Sex work and related issues (6 papers). Michelle Van Handel collaborates with scholars based in United States, Kenya and Finland. Michelle Van Handel's co-authors include Dawn K. Smith, Behnam Badie, Leying Zhang, Jeremy A. Grey, H. Irene Hall, Linda A. Valleroy, Joseph Prejean, Linda J. Koenig, Jo Ellen Stryker and Richard J. Wolitski and has published in prestigious journals such as PLoS ONE, NeuroImage and PEDIATRICS.

In The Last Decade

Michelle Van Handel

28 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition — United States, 2015

2015 299 citations Dawn K. Smith, Michelle Van Handel et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers

Michelle Van Handel

EPIDE

SPS

GHP

IMMUN

Claire Bristow United States

Dafne Dain Gandelman Horovitz Brazil

Minghua Zhuang China

Rachel S. Lee United States

Rana Muzaffar Pakistan

Katherine Brown United States

Lisa Mills United States

Timothy Spelman Australia

Xinjian Zhang United States

Naw Htee Khu United States

Claire Bristow United States

Michelle Van Handel

509 ×0.7

504 ×0.7

EPIDE

99 ×0.4

SPS

291 ×1.1

GHP

37 ×0.2

IMMUN

Citations per year, relative to Michelle Van Handel Michelle Van Handel (= 1×) peers Claire Bristow

Countries citing papers authored by Michelle Van Handel

Since Specialization

Citations

This map shows the geographic impact of Michelle Van Handel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Van Handel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Van Handel more than expected).

Fields of papers citing papers by Michelle Van Handel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Van Handel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Van Handel. The network helps show where Michelle Van Handel may publish in the future.

Co-authorship network of co-authors of Michelle Van Handel

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Van Handel. A scholar is included among the top collaborators of Michelle Van Handel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Van Handel. Michelle Van Handel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Lin, Nathan W. Furukawa, W. Thompson, et al.. (2025). Health and Economic Impact of Periodic Hepatitis C Virus Testing Among People Who Inject Drugs. JAMA Health Forum. 6(7). e251870–e251870. 2 indexed citations

Handel, Michelle Van, Amy L. Sandul, Angela B. Hutchinson, et al.. (2024). Testing trends and co-testing patterns for HIV, hepatitis C and sexually transmitted infections (STIs) in Emergency departments. Preventive Medicine Reports. 44. 102777–102777.

Handel, Michelle Van, et al.. (2023). Cost-effectiveness of expanded hepatitis A vaccination among adults with diagnosed HIV, United States. PLoS ONE. 18(3). e0282972–e0282972. 2 indexed citations

Shrestha, Shikhar, et al.. (2023). Methods for jurisdictional vulnerability assessment of opioid-related outcomes. Preventive Medicine. 170. 107490–107490. 2 indexed citations

Bonacci, Robert A., et al.. (2023). Estimated Uncovered Costs For HIV Preexposure Prophylaxis In The US, 2018. Health Affairs. 42(4). 546–555. 9 indexed citations

Kaufman, Harvey W., Lara Bull–Otterson, William A. Meyer, et al.. (2021). Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic. American Journal of Preventive Medicine. 61(3). 369–376. 60 indexed citations

Shrestha, Shikhar, et al.. (2021). Characterizing opioid-involved overdose risk in local communities: An opioid overdose vulnerability assessment across Indiana, 2017. Preventive Medicine Reports. 24. 101538–101538. 10 indexed citations

Adams, Laura E., Greta M. Massetti, Ana Penman‐Aguilar, et al.. (2021). Counties with High COVID-19 Incidence and Relatively Large Racial and Ethnic Minority Populations — United States, April 1–December 22, 2020. MMWR Morbidity and Mortality Weekly Report. 70(13). 483–489. 23 indexed citations

Evans, Mary E., Marissa K. Person, Brigg Reilley, et al.. (2020). Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014. Public Health Reports. 135(4). 461–471. 4 indexed citations

10.

Krueger, Amy, Michelle Van Handel, Patricia M. Dietz, et al.. (2019). Factors Associated with State Variation in Mortality Among Persons Living with Diagnosed HIV Infection. Journal of Community Health. 44(5). 963–973. 3 indexed citations

11.

Smith, Dawn K., Michelle Van Handel, & Jeremy A. Grey. (2018). Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Annals of Epidemiology. 28(12). 850–857.e9. 189 indexed citations

12.

Krueger, Amy, Patricia M. Dietz, Michelle Van Handel, Lisa Belcher, & Anna Satcher Johnson. (2016). Estimates of CDC-Funded and National HIV Diagnoses: A Comparison by Demographic and HIV-related Factors. AIDS and Behavior. 20(12). 2961–2965. 8 indexed citations

13.

Wejnert, Cyprian, Kristen L. Hess, H. Irene Hall, et al.. (2016). Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs — United States. MMWR Morbidity and Mortality Weekly Report. 65(47). 1336–1342. 84 indexed citations

14.

Handel, Michelle Van, Bridget H. Lyons, Emeka Oraka, et al.. (2015). Factors Associated with Time Since Last HIV Test Among Persons at High Risk for HIV Infection, National Survey of Family Growth, 2006–2010. AIDS Patient Care and STDs. 29(10). 533–540. 8 indexed citations

15.

Hayek, Samah, Patricia M. Dietz, Michelle Van Handel, et al.. (2015). Centers for Disease Control and Prevention Funding for HIV Testing Associated With Higher State Percentage of Persons Tested. Journal of Public Health Management and Practice. 21(6). 531–537. 5 indexed citations

16.

Smith, Dawn K., Michelle Van Handel, Richard J. Wolitski, et al.. (2015). Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition — United States, 2015. MMWR Morbidity and Mortality Weekly Report. 64(46). 1291–1295. 299 indexed citations breakdown →

17.

Dietz, Patricia M., Michelle Van Handel, Huisheng Wang, et al.. (2015). HIV Testing among Outpatients with Medicaid and Commercial Insurance. PLoS ONE. 10(12). e0144965–e0144965. 8 indexed citations

18.

Zhang, Leying, Darya Alizadeh, Michelle Van Handel, et al.. (2009). Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice. Glia. 57(13). 1458–1467. 155 indexed citations

19.

Zhang, Lu, et al.. (2007). Regulation of IL-10 expression by upstream stimulating factor (USF-1) in glioma-associated microglia. Journal of Neuroimmunology. 184(1-2). 188–197. 33 indexed citations

20.

Schartner, Jill, et al.. (2005). Impaired capacity for upregulation of MHC class II in tumor‐associated microglia. Glia. 51(4). 279–285. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact